{"id":"https://openalex.org/W1663154925","doi":"https://doi.org/10.1038/nrd4609","title":"An analysis of the attrition of drug candidates from four major pharmaceutical companies","display_name":"An analysis of the attrition of drug candidates from four major pharmaceutical companies","alternate_titles":[],"publication_year":2015,"publication_date":"2015-06-19","ids":{"openalex":"https://openalex.org/W1663154925","doi":"https://doi.org/10.1038/nrd4609","mag":"1663154925","pmid":"https://pubmed.ncbi.nlm.nih.gov/26091267"},"language":"en","primary_location":{"id":"doi:10.1038/nrd4609","doi":"https://doi.org/10.1038/nrd4609","is_oa":false,"landing_page_url":"https://doi.org/10.1038/nrd4609","pdf_url":null,"source":{"id":"https://openalex.org/S186543748","display_name":"Nature Reviews Drug Discovery","issn_l":"1474-1776","issn":["1474-1776","1474-1784"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319908","host_organization_name":"Nature Portfolio","host_organization_lineage":["https://openalex.org/P4310319908","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Nature Portfolio","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nature Reviews Drug Discovery","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1663154925"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","datacite","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://doi.org/10.25405/ncl.34255107","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Michael J. Waring","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Michael J. Waring","raw_affiliation_strings":["AstraZeneca, Alderley Park, Cheshire SK10 4TG, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca, Alderley Park, Cheshire SK10 4TG, UK","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109939857","display_name":"John E. Arrowsmith","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210090249","display_name":"Thomson Reuters (United Kingdom)","ror":"https://ror.org/008krtd86","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210090249","https://openalex.org/I68384125"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"John Arrowsmith","raw_affiliation_strings":["Thomson Reuters, 77 Hatton Garden, London, EC1N 8JS, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Thomson Reuters, 77 Hatton Garden, London, EC1N 8JS, UK","institution_ids":["https://openalex.org/I4210090249"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036729806","display_name":"Andrew R. Leach","orcid":"https://orcid.org/0000-0001-8178-0253","observed_orcids":["https://orcid.org/0000-0001-8178-0253"]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Andrew R. Leach","raw_affiliation_strings":["GlaxoSmithKline, Stevenage, Hertfordshire SG1 2NY, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline, Stevenage, Hertfordshire SG1 2NY, UK","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037689001","display_name":"Paul D. Leeson","orcid":"https://orcid.org/0000-0003-0212-3437","observed_orcids":["https://orcid.org/0000-0003-0212-3437"]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Paul D. Leeson","raw_affiliation_strings":["1] GlaxoSmithKline, Stevenage, Hertfordshire SG1 2NY, UK. [2] Paul Leeson Consulting, The Malt House, Main Street, Congerstone, Nuneaton, Warwickshire CV13 6LZ, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1] GlaxoSmithKline, Stevenage, Hertfordshire SG1 2NY, UK. [2] Paul Leeson Consulting, The Malt House, Main Street, Congerstone, Nuneaton, Warwickshire CV13 6LZ, UK","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006029703","display_name":"Sam Mandrell","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210090249","display_name":"Thomson Reuters (United Kingdom)","ror":"https://ror.org/008krtd86","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210090249","https://openalex.org/I68384125"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Sam Mandrell","raw_affiliation_strings":["Thomson Reuters, 77 Hatton Garden, London EC1N 8JS, UK","(Thomson Reuters, London, UK)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Thomson Reuters, 77 Hatton Garden, London EC1N 8JS, UK","institution_ids":["https://openalex.org/I4210090249"]},{"raw_affiliation_string":"(Thomson Reuters, London, UK)","institution_ids":["https://openalex.org/I4210090249"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Robert M. Owen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I189718659","display_name":"Pfizer (United Kingdom)","ror":"https://ror.org/04x4v8p40","country_code":"GB","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I189718659"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Robert M. Owen","raw_affiliation_strings":["Pfizer, Cambridge, Cambridgeshire CB21 6GS, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer, Cambridge, Cambridgeshire CB21 6GS, UK","institution_ids":["https://openalex.org/I189718659"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091180633","display_name":"Garry Pairaudeau","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Garry Pairaudeau","raw_affiliation_strings":["AstraZeneca, Alderley Park, Cheshire SK10 4TG, UK","AstraZeneca  Cheshire UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca, Alderley Park, Cheshire SK10 4TG, UK","institution_ids":["https://openalex.org/I105036370"]},{"raw_affiliation_string":"AstraZeneca  Cheshire UK","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112508806","display_name":"William D. Pennie","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"William D. Pennie","raw_affiliation_strings":["1] Pfizer, Groton, Connecticut 06340, USA. [2] Takeda Pharmaceuticals, Cambridge, Massachusetts 02139, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1] Pfizer, Groton, Connecticut 06340, USA. [2] Takeda Pharmaceuticals, Cambridge, Massachusetts 02139, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079075074","display_name":"Stephen D. Pickett","orcid":"https://orcid.org/0000-0002-0958-9830","observed_orcids":["https://orcid.org/0000-0002-0958-9830"]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Stephen D. Pickett","raw_affiliation_strings":["GlaxoSmithKline, Stevenage, Hertfordshire SG1 2NY, UK","GlaxoSmithKline, Stevenage, UK;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline, Stevenage, Hertfordshire SG1 2NY, UK","institution_ids":["https://openalex.org/I188950975"]},{"raw_affiliation_string":"GlaxoSmithKline, Stevenage, UK;","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Jibo Wang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jibo Wang","raw_affiliation_strings":["Eli Lilly, Indianapolis, Indiana 46285, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly, Indianapolis, Indiana 46285, USA","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049853983","display_name":"Owen B. Wallace","orcid":"https://orcid.org/0000-0001-8162-8593","observed_orcids":["https://orcid.org/0000-0001-8162-8593"]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Owen Wallace","raw_affiliation_strings":["1] Eli Lilly, Indianapolis, Indiana 46285, USA. [2] Novartis Institutes for Biomedical Research, Cambridge, Massachusetts 02139, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1] Eli Lilly, Indianapolis, Indiana 46285, USA. [2] Novartis Institutes for Biomedical Research, Cambridge, Massachusetts 02139, USA","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"last","author":{"id":null,"display_name":"Alex Weir","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210090249","display_name":"Thomson Reuters (United Kingdom)","ror":"https://ror.org/008krtd86","country_code":"GB","type":"company","lineage":["https://openalex.org/I4210090249","https://openalex.org/I68384125"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Alex Weir","raw_affiliation_strings":["Thomson Reuters, 77 Hatton Garden, London EC1N 8JS, UK","(Thomson Reuters, London, UK)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Thomson Reuters, 77 Hatton Garden, London EC1N 8JS, UK","institution_ids":["https://openalex.org/I4210090249"]},{"raw_affiliation_string":"(Thomson Reuters, London, UK)","institution_ids":["https://openalex.org/I4210090249"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":5,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I105036370"],"apc_list":null,"apc_paid":null,"fwci":11.3691,"has_fulltext":false,"cited_by_count":1668,"citation_normalized_percentile":{"value":0.98876404,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":99,"max":100},"biblio":{"volume":"14","issue":"7","first_page":"475","last_page":"486"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.9848999977111816,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.9848999977111816,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.0020000000949949026,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.0019000000320374966,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/drug-attrition","display_name":"drug attrition","score":0.9599999785423279},{"id":"https://openalex.org/keywords/small-molecule-drug-candidates","display_name":"small molecule drug candidates","score":0.9459999799728394},{"id":"https://openalex.org/keywords/physicochemical-properties","display_name":"physicochemical properties","score":0.9700000286102295},{"id":"https://openalex.org/keywords/clinical-failure","display_name":"clinical failure","score":0.6970000267028809},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.890999972820282},{"id":"https://openalex.org/keywords/compound-optimization","display_name":"compound optimization","score":0.777999997138977},{"id":"https://openalex.org/keywords/oral-medication","display_name":"oral medication","score":0.6909999847412109},{"id":"https://openalex.org/keywords/pharmaceutical-industry","display_name":"pharmaceutical industry","score":0.8220000267028809}],"concepts":[{"id":"https://openalex.org/C2780553607","wikidata":"https://www.wikidata.org/wiki/Q684868","display_name":"Attrition","level":2,"score":0.8550056219100952},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.6275021433830261},{"id":"https://openalex.org/C2779652045","wikidata":"https://www.wikidata.org/wiki/Q507443","display_name":"Pharmaceutical industry","level":2,"score":0.5198088884353638},{"id":"https://openalex.org/C2779530757","wikidata":"https://www.wikidata.org/wiki/Q1207505","display_name":"Quality (philosophy)","level":2,"score":0.4481286108493805},{"id":"https://openalex.org/C112930515","wikidata":"https://www.wikidata.org/wiki/Q4389547","display_name":"Risk analysis (engineering)","level":1,"score":0.4053650498390198},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3903943598270416},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.387952983379364},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2851627469062805},{"id":"https://openalex.org/C138885662","wikidata":"https://www.wikidata.org/wiki/Q5891","display_name":"Philosophy","level":0,"score":0.0},{"id":"https://openalex.org/C111472728","wikidata":"https://www.wikidata.org/wiki/Q9471","display_name":"Epistemology","level":1,"score":0.0},{"id":"https://openalex.org/C199343813","wikidata":"https://www.wikidata.org/wiki/Q12128","display_name":"Dentistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004345","descriptor_name":"Drug Industry","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D004345","descriptor_name":"Drug Industry","qualifier_ui":"Q000639","qualifier_name":"trends","is_major_topic":false},{"descriptor_ui":"D004345","descriptor_name":"Drug Industry","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false},{"descriptor_ui":"D004353","descriptor_name":"Drug Evaluation, Preclinical","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D004353","descriptor_name":"Drug Evaluation, Preclinical","qualifier_ui":"Q000639","qualifier_name":"trends","is_major_topic":false},{"descriptor_ui":"D004353","descriptor_name":"Drug Evaluation, Preclinical","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013223","descriptor_name":"Statistics as Topic","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D013223","descriptor_name":"Statistics as Topic","qualifier_ui":"Q000639","qualifier_name":"trends","is_major_topic":false},{"descriptor_ui":"D015507","descriptor_name":"Drugs, Investigational","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D016503","descriptor_name":"Drug Delivery Systems","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D016503","descriptor_name":"Drug Delivery Systems","qualifier_ui":"Q000639","qualifier_name":"trends","is_major_topic":false},{"descriptor_ui":"D016503","descriptor_name":"Drug Delivery Systems","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false},{"descriptor_ui":"D055808","descriptor_name":"Drug Discovery","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D055808","descriptor_name":"Drug Discovery","qualifier_ui":"Q000639","qualifier_name":"trends","is_major_topic":false},{"descriptor_ui":"D055808","descriptor_name":"Drug Discovery","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1038/nrd4609","doi":"https://doi.org/10.1038/nrd4609","is_oa":false,"landing_page_url":"https://doi.org/10.1038/nrd4609","pdf_url":null,"source":{"id":"https://openalex.org/S186543748","display_name":"Nature Reviews Drug Discovery","issn_l":"1474-1776","issn":["1474-1776","1474-1784"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319908","host_organization_name":"Nature Portfolio","host_organization_lineage":["https://openalex.org/P4310319908","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Nature Portfolio","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nature Reviews Drug Discovery","raw_type":"journal-article"},{"id":"pmid:26091267","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/26091267","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nature reviews. Drug discovery","raw_type":"Journal Article"},{"id":"doi:10.25405/ncl.34255107","doi":"https://doi.org/10.25405/ncl.34255107","is_oa":true,"landing_page_url":"https://doi.org/10.25405/ncl.34255107","pdf_url":null,"source":{"id":"https://openalex.org/S4306402485","display_name":"Newcastle University ePrints (Newcastle Univesity)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I84884186","host_organization_name":"Newcastle University","host_organization_lineage":["https://openalex.org/I84884186"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"},{"id":"doi:10.25405/ncl.34255107.v1","doi":"https://doi.org/10.25405/ncl.34255107.v1","is_oa":true,"landing_page_url":"https://doi.org/10.25405/ncl.34255107.v1","pdf_url":null,"source":{"id":"https://openalex.org/S4306402485","display_name":"Newcastle University ePrints (Newcastle Univesity)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I84884186","host_organization_name":"Newcastle University","host_organization_lineage":["https://openalex.org/I84884186"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"}],"best_oa_location":{"id":"doi:10.25405/ncl.34255107","doi":"https://doi.org/10.25405/ncl.34255107","is_oa":true,"landing_page_url":"https://doi.org/10.25405/ncl.34255107","pdf_url":null,"source":{"id":"https://openalex.org/S4306402485","display_name":"Newcastle University ePrints (Newcastle Univesity)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I84884186","host_organization_name":"Newcastle University","host_organization_lineage":["https://openalex.org/I84884186"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"},"sustainable_development_goals":[{"score":0.8371999859809875,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":27,"referenced_works":["https://openalex.org/W1895993106","https://openalex.org/W1967105697","https://openalex.org/W1989605329","https://openalex.org/W1996973304","https://openalex.org/W1997362383","https://openalex.org/W2014084301","https://openalex.org/W2014203427","https://openalex.org/W2018453465","https://openalex.org/W2030952396","https://openalex.org/W2038094422","https://openalex.org/W2042721486","https://openalex.org/W2049425802","https://openalex.org/W2051786044","https://openalex.org/W2058298068","https://openalex.org/W2062458432","https://openalex.org/W2069506489","https://openalex.org/W2073434092","https://openalex.org/W2074274985","https://openalex.org/W2083354933","https://openalex.org/W2085313599","https://openalex.org/W2092201972","https://openalex.org/W2097559461","https://openalex.org/W2127451270","https://openalex.org/W2148103576","https://openalex.org/W2160384674","https://openalex.org/W2316253021","https://openalex.org/W4248107770"],"related_works":["https://openalex.org/W2734485602","https://openalex.org/W1608404542","https://openalex.org/W2326124692","https://openalex.org/W2342141604","https://openalex.org/W2336612894","https://openalex.org/W2092201972","https://openalex.org/W4296177526","https://openalex.org/W2555298309","https://openalex.org/W2265028324","https://openalex.org/W103689249"],"abstract_inverted_index":null,"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1663154925","counts_by_year":[{"year":2026,"cited_by_count":227},{"year":2025,"cited_by_count":147},{"year":2024,"cited_by_count":169},{"year":2023,"cited_by_count":151},{"year":2022,"cited_by_count":147},{"year":2021,"cited_by_count":142},{"year":2020,"cited_by_count":144},{"year":2019,"cited_by_count":147},{"year":2018,"cited_by_count":149},{"year":2017,"cited_by_count":129},{"year":2016,"cited_by_count":100},{"year":2015,"cited_by_count":12}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2016-06-24T00:00:00"}
